Evidence map›Paper›PMID 30444175›Full record

ArticleJournal of neurotrauma2019

Matrix Metalloproteinase 9 and Osteopontin Interact to Support Synaptogenesis in the Olfactory Bulb after Mild Traumatic Brain Injury.

Melissa A Powell, Raiford T Black, Terry L Smith, Thomas M Reeves, Linda L Phillips

Open access · greenAbstract read
In one paragraph

Article in Journal of neurotrauma, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Potential Progression Mechanism and Key Genes in Early Stage of mTBI.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Melissa A PowellDepartment of Anatomy and Neurobiology, School of Medicine, Virginia Commonwealth University Medical Center, Richmond, Virgina.
Raiford T BlackDepartment of Anatomy and Neurobiology, School of Medicine, Virginia Commonwealth University Medical Center, Richmond, Virgina.
Terry L SmithDepartment of Anatomy and Neurobiology, School of Medicine, Virginia Commonwealth University Medical Center, Richmond, Virgina.
Thomas M ReevesDepartment of Anatomy and Neurobiology, School of Medicine, Virginia Commonwealth University Medical Center, Richmond, Virgina.
Linda L PhillipsDepartment of Anatomy and Neurobiology, School of Medicine, Virginia Commonwealth University Medical Center, Richmond, Virgina.
Virginia Commonwealth University · US

Funding

Virus Vector Shared ResourceP30CA016059 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Kim Felder Rhoads · 1985 to 2026
$51.0M
Extracellular Matrix Mediates Axonal Integrity Following Brain TraumaR01NS056247 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI PHILLIPS, LINDA L. · 2007 to 2017
$3.4M
New Approaches to Axonal Protection After TBIR01NS057758 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI REEVES, THOMAS M. · 2007 to 2017
$3.3M
Matrix Metalloproteinases and Regenerative Plasticity Following Brain InjuryR01NS044372 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI PHILLIPS, LINDA L. · 2002 to 2011
$2.9M
Matrix Metalloproteinases and Regenerative Plasticity Following Brain InjuryR56NS044372 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI PHILLIPS, LINDA L. · 2007 to 2007
$373k
NCI NIH HHS P30 CA016059NINDS NIH HHS R01 NS044372NINDS NIH HHS R01 NS056247NINDS NIH HHS R01 NS057758NINDS NIH HHS R56 NS044372
6 · The paper itself

Abstract

Olfactory receptor axons reinnervate the olfactory bulb (OB) after chemical or transection lesion. Diffuse brain injury damages the same axons, but the time course and regulators of OB reinnervation are unknown. Gelatinases (matrix metalloproteinase [MMP]2, MMP9) and their substrate osteopontin (OPN) are candidate mediators of synaptogenesis after central nervous system (CNS) insult, including olfactory axon damage. Here, we examined the time course of MMP9, OPN, and OPN receptor CD44 response to diffuse OB injury. FVBV/NJ mice received mild midline fluid percussion insult (mFPI), after which MMP9 activity and both OPN and CD44 protein expression were measured. Diffuse mFPI induced time-dependent increase in OB MMP9 activity and elevated the cell signaling 48-kD OPN fragment. This response was bimodal at 1 and 7 days post-injury. MMP9 activity was also correlated with 7-day reduction in a second 32-kD OPN peptide. CD44 increase peaked at 3 days, delayed relative to MMP9/OPN response. MMP9 and OPN immunohistochemistry suggested that deafferented tufted and mitral neurons were the principal sites for these molecular interactions. Analysis of injured MMP9 knockout (KO) mice showed that 48-kD OPN production was dependent on OB MMP9 activity, but with no KO effect on CD44 induction. Olfactory marker protein (OMP), used to identify injured olfactory axons, revealed persistent axon damage in the absence of MMP9. MMP9 KO ultrastructure at 21 days post-injury indicated that persistent OMP reduction was paired with delayed removal of degenerated axons. These results provide evidence that diffuse, concussive brain trauma induces a post-injury interaction between MMP9, OPN, and CD44, which mediates synaptic plasticity and reinnervation within the OB.

Indexed as

AnimalsBrain ConcussionHyaluronan ReceptorsMatrix Metalloproteinase 9MiceMice, KnockoutNeurogenesisNeuronal PlasticityOlfactory BulbOsteopontinSynapsesCd44 protein, mouseHyaluronan ReceptorsMatrix Metalloproteinase 9Mmp9 protein, mouseOsteopontinSpp1 protein, mousemetalloproteinaseolfactory bulbosteopontinsynaptogenesis

Identifiers

PMID30444175
PMCPMC6531908
OpenAlexW2901866761

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.